Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19 by Edward Richardson, Clifton C. Mo, Eleonora Calabretta, Francesco Corrado, Mehmet H. Kocoglu, Rebecca M. Baron, Jean Marie Connors, Massimo Iacobelli, Lee-Jen Wei, Emily J. Benjamin, Aaron P. Rapoport, Maribel Díaz-Ricart, Antonio José Martínez-Mellado, Carmelo Carlo-Stella, Paul G. Richardson, José M. Moraleda

Subjects: Get full text

Injection site reaction to teclistamab in a patient with multiple myeloma by Isabel C. Yoon, BS, Ngan Do, MD, Thomas Vazquez, MD, David E. Elder, MD, Katherine T. Steele, MD, Misha Rosenbach, MD

Subjects: “…bispecific antibodies…”
Get full text

Clinical progress of cadonilimab in the treatment of malignant tumor by ZHANG Xiaoqing, LIU Shuai, ZHANG Kai, WANG Yuchao, HE Jing, LUAN Wei

Subjects: Get full text

BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA by Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo

Subjects: Get full text

Current advances in bispecific T cell–engaging therapies by Emmanuel Owusu Ansah, Benard Ansong, Foster Kyei

Subjects: “…bispecific, immunotherapy, cancer, cytokine, antibodies…”
Get full text

T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer by S. M. Greiner, J. Mauermann, M. S. Lutz, I. Hagelstein, A. D. Hartkopf, L. Zekri, G. Jung, H. R. Salih, M. Märklin

Subjects: Get full text

Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatment by Lauren C. Naatz, Shuyun Dong, Brian Evavold, Xiangyang Ye, Mingnan Chen

Subjects: Get full text

Developability considerations for bispecific and multispecific antibodies by Alaa Amash, Gesa Volkers, Patrick Farber, Daniel Griffin, K. Shawn Davison, Allison Goodman, Raffi Tonikian, Aaron Yamniuk, Bryan Barnhart, Tim Jacobs

Subjects: Get full text

Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλ interface by John D. Bagert, Vaheh Oganesyan, Chi-I Chiang, Mike Iannotti, Jia Lin, Chunning Yang, Sterling Payne, Will McMahon, Samuel Edwards, Andrew Dippel, Mark Hutchinson, Fengying Huang, Vineela Aleti, Chendi Niu, Chen Qian, Jessica Denham, Sofia Ferreira, Pallab Pradhan, Mark Penney, Chunlei Wang, Wenhai Liu, Even Walseng, Yariv Mazor

Subjects: Get full text

The silent signals: emerging safety concerns in bispecific antibody therapy for multiple myeloma by Xiaoling Zhou, Erdan Luo, Wei Chen, Yi Deng, Bo Wu, Xia Jiang, Kaili Zhang, Fan Lai

Subjects: “…bispecific antibodies…”
Get full text

Immunological synapse formation as a key mechanism in T cell-dependent bispecific antibody-mediated immune activation and cytotoxicity by Rikuto Nakamura, Ryo Tsumura, Takahiro Anzai, Ryutaro Asano, Masahiro Yasunaga

Subjects: Get full text

Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma by Andrée-Anne Pelland, Mathilde Dumas, Émilie Lemieux-Blanchard, Richard LeBlanc, Julie Côté, Jean-Samuel Boudreault, Dominic Duquette, Rayan Kaedbey, Marc Lalancette, Frédéric Larose, Anna Nikonova, Michel Pavic, April Shamy, Jean Roy, Michael Sebag, Sabrina Trudel, Jean-Sébastien Claveau

Subjects: “…bispecific antibodies…”
Get full text

Improving CD3 bispecific antibody therapy in solid tumors using combination strategies by Katy Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, Nora Pencheva, Kristel Kemper, Thorbald van Hall

Subjects: Get full text

Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review) by ON Solopova, VA Misyurin

Subjects: “…bispecific antibodies…”
Get full text

Kinetic analysis of ternary and binary binding modes of the bispecific antibody emicizumab by Stefanie Mak, Agnes Marszal, Nena Matscheko, Ulrich Rant

Subjects: “…Bispecific…”
Get full text

Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies by Ailawadhi S, Biru Y, Clavreul S, San Miguel M, Cormier N, Efebera Y, Merz M, Sato A, Zeanah C, Watkins JL, Farrell J, Goldman EH, Popat R

Subjects: “…bispecific antibodies…”
Get full text

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma by Masaud Shah, Muhammad Hussain, Hyun Goo Woo

Subjects: Get full text

Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment by Saqib Raza Khan, Daniel Breadner

Subjects: Get full text

Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions by Michael Mullin, James McClory, Winston Haynes, Justin Grace, Nathan Robertson, Gino van Heeke

Subjects: Get full text

A Model‐Based Approach to Evaluate Anti‐Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T‐Cell Bispecific Cibisatamab by Javier Sanchez, Philippe B. Pierrillas, Nicolas Frey, Gregor P. Lotz, Siv Jönsson, Lena E. Friberg, Nicolas Frances

Subjects: Get full text